Investment
Features
FeesSafety
Academy
More
Pluang+

Amplify CWP International Enhanced Dividend Income ETF yields 5.61%, targets 8-12% returns with active sector shifts.

Analyst Insights
11 Aug 2026
Seeking Alpha
View Source
Bullish
pluang ai news

The Amplify CWP International Enhanced Dividend Income ETF offers a 5.61% trailing twelve months yield and actively adjusts its portfolio toward sectors like financials and technology that are expected to outperform. This strategy aims to capture evolving leadership in international markets, with an anticipated total return of 8% to 12% over the next 6 to 12 months, supported by healthy international earnings and sector diversification. Covered calls are used to enhance income without fully limiting upside potential, though broad market rallies may reduce its relative performance compared to passive ETFs. The ETF is recommended as a buy for investors seeking income and growth in international stocks amid changing market dynamics.

More News

Alumis stock plunges 57% after lupus drug trial fails, but psoriasis drug progress continues.

Alumis stock plunges 57% after lupus drug trial fails, but psoriasis drug progress continues.

Alumis' stock dropped 56.58% after its Phase II lupus drug trial failed to meet main goals, causing a significant market reaction. However, positive results in a subgroup of lupus patients with a high interferon gene signature offer a potential path ...

Market News
Bearish
3 hours ago
SPACs, biotech, geothermal, and AI stocks rally with major deals and volatility driving gains

SPACs, biotech, geothermal, and AI stocks rally with major deals and volatility driving gains

SPAC stocks like Rising Dragon Acquisition surged nearly 47% amid volatility, while biotech firm bioAffinity Technologies jumped 44% after a reverse stock split. Renewable energy company Fervo Energy gained 28% following a major geothermal power deal...

Market News
Bullish
4 hours ago
Alumis plunges 57% after trial failure; Enovis falls 16% on robotics acquisition news

Alumis plunges 57% after trial failure; Enovis falls 16% on robotics acquisition news

Alumis Inc. shares dropped 56.76% after its Phase 2b trial for a lupus drug failed to meet key goals, though some patient groups showed promise. Enovis Corporation shares fell 16.51% following its announcement to acquire eCential Robotics for €155 mi...

Market News
Bearish
4 hours ago
Vault Strategic Mining amends private placement terms to raise up to $1.5M for exploration and corporate use.

Vault Strategic Mining amends private placement terms to raise up to $1.5M for exploration and corporate use.

Vault Strategic Mining Corp has updated the terms of its non-brokered private placement, now offering up to 12 million units at $0.125 each, aiming to raise $1.5 million. Each unit includes one common share and one warrant exercisable at $0.20 within...

Company Fundamentals
Bullish
4 hours ago
Enovis cuts price target to $27 amid €155M robotics acquisition, stock drops 16.5%.

Enovis cuts price target to $27 amid €155M robotics acquisition, stock drops 16.5%.

Enovis has lowered its price target to $27 from $30 following its binding offer to acquire eCential Robotics for €155 million. This acquisition aims to strengthen Enovis's position in surgical robotics and enhance its ASTRA technology ecosystem. Desp...

Market News
Bearish
4 hours ago
banner-footerbanner-footer

Invest & Trade with
#1 Award-Winning Investment Super App